Manufacturing, Recombinant Proteins

MilliporeSigma’s ZooMAb Antibodies Earn ACT Label from My Green Lab

May 09, 2022

MilliporeSigma’s ZooMAb antibodies have been recognized for their low environmental impact by My Green Lab.

Thermo Fisher Scientific Opens Biologics Manufacturing Site in Lengnau, Switzerland

October 04, 2021

Thermo Fisher’s new Swiss facility will initially produce CSL Limited’s recombinant factor IX product Idelvion.

BioVaxys and WuXi to Collaborate on SARS-CoV-2 S-Protein Production

March 15, 2021

WuXi will produce SARS-CoV-2 s-proteins for BioVaxys’ COVID-19 vaccine candidate, BVX-0320, and for its Covid-T immunodiagnostic program.

Novavax Expands COVID-19 Collaboration and License Agreement with SK Bioscience

February 17, 2021

The companies have expanded their existing partnership to include 40 Million Doses of COVID-19 vaccine for South Korea.

NSERC Awards Alliance Grant to PlantForm to Enable Commercial-Scale Production of Protein Therapeutics

December 02, 2020

The grant will support the advancement of glycoengineering technology for plant-derived proteins developed by a University of Alberta scientist partnered with PlantForm.

AGC Biologics Adds Mammalian Production Capacity in Japan

October 11, 2018

The new facility will include comprehensive mammalian process development and manufacturing capabilities.

Chromatography Resin Designed to Boost Process-Scale Productivity

September 07, 2018

Bio-Rad introduces CHT Ceramic Hydroxyapatite XT media and Nuvia HP-Q resin resin for process protein purification.

Wuxi Biologics to Install Large-Scale Single-Use Bioreactor

March 22, 2018

The company plans to install 4000-L disposable bioreactors from ABEC at its new commercial manufacturing facility in Wuxi city, China.

Shire, AB Biosciences Enter Autoimmune Disease Agreement

February 02, 2018

Shire will receive exclusive license to develop and commercialize AB Biosciences' pan receptor interacting molecule program for autoimmune and inflammatory diseases.

Univercells to Develop Antibody Production Platform with $2.9-Million Grant

January 23, 2018

The funding from the Walloon Region will enable Univercells to start developing a manufacturing platform aimed at driving down costs of biosimilars manufacturing.